蛋白别名: PKC-B; Protein kinase C beta type; protein kinase C, beta 1 polypeptide 基因别名: PKC-beta; PKCB; PRKCB; PRKCB1; PRKCB2 UniProt ID: (Human) P05771 Entrez Gene ID: (Human) 5579 随时为您服务 获取常见问题的专家解答,或者直接联系我们的技术专家,咨询应用、设备、常规产品使用问...
PKC Beta/PRKCB抗体 英文名称: Anti-PKC Beta/PRKCB Antibody 产品规格: 50μl|100μl|150μl 发货周期: 1~3天 产品价格: 询价 本产品仅可用于科研实验,严禁用于其他非科研用途! 抗体名称Anti-PKC Beta/PRKCB Antibody 指标别名PKC B;PKC beta;PKCB;PRKCB;PRKCB1;PRKCB2;Protein kinase C beta type;prote...
Roman BB, Geenen DL, Leitges M & Buttrick PM (2001) PKC-Beta Is Not Necessary for Cardiac Hypertrophy. Am J Physiol Heart Circ Physiol 280 : H2264-H2270.PKC-beta is not necessary for cardiac hypertrophy. Roman BB,Geenen DL,Leitges M,Buttrick PM. Am. J. Physiol. Heart Circ. ...
英文名称:PKC-IN-1 分子式:C25H37FN8O2 纯度:99.50% 产地:北京 包装规格:1mL(10mM)|2mg|5mg|10mg|50mg|100mg 品牌:百奥莱博 货号:M07808 CAS编号:1046787-18-1 特别提示:包括PKC beta II抑制剂(PKC-IN-1)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
抗体名:PKC beta 1 + 2 浓度:1mg/ml % 靶点:详见说明书 宿主:详见说明书 用途:仅供科研使用 应用范围:WB=1:500-2000,Elisa=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,Flow Cyt=1:ug/Test,IF=1:100-500, 纯度:1mg/ml % 产地:国内 ...
上海沪震实业有限公司主要致力于“PKC beta 1 + 2抗体 ”的生产销售。多年的“PKC beta 1 + 2抗体 ”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大用户信赖。欢迎来电咨询或前来选购。 联系电话:021-60345367。
PKC-BETAI Basic informationSupplier Basic informationMore Product Name:PKC-BETAI Synonyms:PKC-BETAIPROTEIN KINASE C-BETA-I STANDARD, HUMANPROTEIN KINASE CBETAI STANDARD, HUMAN, RECOMBINANTPROTEIN KINASE C-BETA-IPROTEIN KINASE C-BETAI, HUMANPROTEIN KINASE CBETAI, HUMAN, RECOMBINANT, SPODOPTERA ...
基因别名: PKC-beta; PKCB; PRKCB; PRKCB1; PRKCB2 UniProt ID: (Human) P05771 Entrez Gene ID: (Human) 5579 功能 chromatin binding protein serine/threonine kinase activity protein kinase C activity calcium-dependent protein kinase C activity protein kinase C binding calcium channel regulator...
PKC-beta and PKC-zeta mediate opposing effects on proximal tubule Na+,K+-ATPase activity. 来自 Wiley 喜欢 0 阅读量: 47 作者: R Efendiev,AM Bertorello,CH Pedemonte 展开 摘要: Dopamine (DA) inhibits rodent proximal tubule Na + ,K + -ATPase via stimulation of protein kinase C (...
Twenty-six cases (34%) were positive for PKC-beta 2 protein, and 50 (66%) were negative. Patients with PKC-beta-2-positive tumors showed a lower complete remission rate (31 vs 62%; P =0.015) and a lower 5-year disease-free survival (DFS) (30 vs 60%; P =0.03) than the PKC-...